Allied Market Research today published a new market research report titled “Flow Cytometry Market (Products, Application, Technology, and Users) – Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020”. As per the study, the flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9%. Increasing needs to enhance precisions and produce faster results as well as need for compact devices are compelling the clinical and diagnostic organization to adopt innovative technologies. Though popularity has been gained in the application field of life science industry, the cost of the instrument is impeding the growth. Due to this, many researchers are still reluctant in adopting this technology in their research work. Moreover, advancing technologies that has brought complex instrumentation requires highly skilled personals to operate these instruments.
The complete report is available at http://www.alliedmarketresearch.com/flow-cytometry-market
“Flow cytometry market is in developing phase. Enhancing precision in results and presence of numerous flow cytometry techniques such as multicolor and multi-parameter flow cytometry has acted as a strong foothold, assisting the market growth in majority of the developed economies and foresees high potential in the emerging economies such as Asia Pacific and Africa. These economies have high demand for better health care techniques at an affordable cost. Increasing aged population who need better healthcare, increase in chronic disease and need for better diagnosis and treatment are few driving factors that are impacting the flow cytometry market” state AMR analysts Debbie Shields and Rohini Patil.
Immunotyping and signal transduction, for example, have been playing a significant role in medical diagnostics. However, conventional technologies used, have limited the accuracy and impacted the result deliverance time of the diagnosis performed. Improving therapeutic scenario is equally attracting focus on early diagnostic tools. Currently, many cancer types have various treatment options; however, this depends on the time of diagnosis and the stage of the cancer. Flow cytometry has been one of the most prevalent technologies which offer solutions for most of the problems discussed above. Key factors restraining the market include high instrument costs and size, lack of awareness among probable users and need for trained personnel. Most of the users are not aware of the advanced development in the flow cytometry technology and believe that the instruments are space consuming, complex in use and are of high cost, thus affecting the market growth.
The global market for flow cytometry is divided into segments such as products, technology, end users, and applications. Instruments market accounts for the largest share of revenue in the flow cytometry market at present and is expected to remain as the highest revenue generator in 2020. Increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction are few of the significant trends in the market assisting in adoption of the instruments by the end users. On the other hand, reagents market is expected to experience the highest growth rate of CAGR 12% during the analysis period. Primary reason escalating this segment is availability of several types of reagents that find diverse usability depending on specific applications like diagnostics, drug discovery, etc.
Two technologies are implemented in flow cytometry based research and diagnosis, namely cell based and bead based technologies. In the present scenario as well as throughout the analysis period, cell based technique is leading the market in terms of revenue generation. However, bead based technique is expected to beat this technology in terms of adoption rate by 2020.
North America accounted for the largest share of revenue i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011. The region is further expected to attain a market size of $2.8 billion by 2020 growing at a CAGR of 10.1%. The company profile in this includes: Advanced analytical Technologies, Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter, eBioscience, Partech, Life technologies corp., Luminex Corp, Amnis Corp., Morphosys AG. The primary strategy employed by key players of the market is products launch which is due to demand for newer, faster, and high through put machines that deliver better results.
The new market research report titled “Food Traceability Market (Tracking Technologies) Global Industry Analysis, Size, Share, Trends, Opportunities and Forecast, 2012 – 2020” is published today by Allied Market Research. As per the market study, the global food traceability market (tracking technologies) is expected to grow at a CAGR of 8.7% during the analysis period, reaching expected revenue of $14.1 billion by 2020. The RFID technology is expected to grow at the highest rate of 19.4% among all technologies of food traceability market. The reason for the high growth rate of RFID is real-time tracking of food items irrespective of weather conditions or location. Accurate read-write ability in complex environment is also a significant advantage of this technology.
Food traceability is becoming a norm for all food producers across the globe as a result of consumer demands and government regulations concerning food safety. Early adoption of food tracking technologies in developed nations such as the U.S., Japan and Australia has led to good market revenues. However, globalization of the food market has increased the importance of a traceability system even in developing nations and therein lie the opportunities for food traceability suppliers to enhance their market position.
Get full access of the report at http://www.alliedmarketresearch.com/food-traceability-tracking-market
Installation of food traceability system requires huge upfront investment, which proves to be a restraint for the market, as small players are not ready to make the extra investments. However, growing awareness and technological advancements leading to lesser investments will overcome this restraint, thus reducing impact on the market in the future. One of the segments discussed in the report is the end-users of the market such as food producers, retailers, warehouses, transportation companies, etc. Food manufacturers are expected to generate maximum revenue of $5.4 billion by 2020 at a CAGR of 11.5% during the analysis period. Another segment of the report discusses the equipment market of food traceability such as 1D and 2D scanners, sensors, tags and labels and PDAs with GPS. The sensors are expected to grow at the highest rate among all the equipment at a CAGR of 10.5% from 2012 to 2020.
The geographic segment of the food traceability market covers North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is expected to generate maximum revenue by 2018 however; Asia Pacific will take over the North American market by 2020. North America is expected to generate $4.4 billion by 2020 at a CAGR of 4.6% during the analysis period. Asia Pacific is expected to have the highest revenues by 2020 as it is expected to grow at a CAGR of 16.7% during 2013-2020.
The study also offers an updated review on the present major market players such as Honeywell, C.H. Robinson, DuPont, Intermec, Motorola Solutions, Cognex, Mass Group, Bio-Rad Laboratories, IBM Corp and Zebra Technologies.
According to lead analyst Lita Person, food tracking technologies are not yet fully deployed in developing economies. Additionally, a lack of standards is impacting the integration and utility of food traceability systems. However, there is an increasing awareness about the importance of efficient food traceability systems in such countries. Stringent food traceability laws in the U.S. and Europe are compelling the food exporters from these nations to enhance their traceability processes. With more active global participants entering into developing economies, there is significant scope to integrate food tracking technologies and derive their utility across the globe.
Global Umbilical Cord Blood Stem Cell Market is Expected to Reach $56.4 Billion by 2020 – Allied Market Research
Allied Market Research today announced the most comprehensive and strategically analyzed report titled “Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) – Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 – 2020″ The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012.Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4%during 2013 to 2020.The storage service market was valued at $7.4billion in 2013.
Get Full access of the report at http://www.alliedmarketresearch.com/stem-cell-umbilical-cord-blood-UCB-market
“Cord blood stem cell application is increasing at faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting thehealthcare industry to discover novel therapies on chronic diseases. UCB stem cell market is evidencing significant growth due to increasing public awareness and government support.”state Allied Market Research analyst Debbie Shields and Roshan Deshmukh.
Increase in prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries however patents for UCB stem cells are comparatively less in developing economies.
According to lead analyst Debbie Shields, the geographicanalysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies.Company profiles in this report include – Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.